Splenic ellipsoids: an early target for deposition of AA amyloid induced in mink

References

• Wien T N, Landsverk T, Espenes A, Gunnes G, Nordstoga K, Husby G. Splenic deposition of AA amyloid may be enhanced by Apo A in ellipsoids. Amyloid and Amyloidosis, R A Kyle, M A Gertz. Parthenon Publishing, New York 1998; 372–374
   Google Scholar
• Schweigger‐Seidel F. Untersuchungen uber die Milz. Virchows Archiv [Pathol Anat] 1863; 27: 460–504
   Google Scholar
• Blue J, Weiss L. Periarterial macrophage sheaths (ellipsoids) in cat spleen ‐ an electron microscope study. Am J Anat 1981; 161: 115–134
   PubMedGoogle Scholar
• Snook T. A comparative study of the vascular arrangements in mammalian spleens. Am J Anat 1950; 87: 31–77
   PubMedGoogle Scholar
• Dustin P. Ultrastructure and function of the ellipsoids of the spleen. Their relationship with fat metabolism and red blood cells. Haematologica 1975; 60: 136–155
   PubMedGoogle Scholar
• Buyssens N, Paulus G, Bourgeois N. Ellipsoids in the human spleen. Virchows Arch A Pathol Anat Histopathol 1984; 403: 27–40
   PubMedGoogle Scholar
• Nossal G J, Austin C M, Pye J, Mitchell J. Antigens in immunity. XII. Antigen trapping in the spleen. Int Arch Allergy Appl Immunol 1966; 29: 368–383
   PubMedGoogle Scholar
• Dustin P. The ellipsoids (sheaths of Schweigger‐Seidel) of the human spleen in various pathological conditions. J Pathol 1971; 104: ii
   PubMedGoogle Scholar
• Husby G. Amyloidosis. Semin Arthritis Rheum 1992; 22: 67–82
   PubMedGoogle Scholar
• Kisilevsky R, Boudreau L. Kinetics of amyloid deposition. I. The effects of amyloid‐enhancing factor and splenectomy. Lab Invest 1983; 48: 53–59
   PubMed Web of Science ®Google Scholar
• Wien T N, Omtvedt L A, Landsverk T, Husby G. Characterization of proteoglycans and glycosaminoglycans in splenic AA amyloid induced in mink. Scand J Immunol 2000; 52: 576–583
   PubMed Web of Science ®Google Scholar
• Puchtler H, Sweat F, Levine M. On the binding of Congo red by amyloid. J Histochem Cytochem 1962; 10: 355–364
   Web of Science ®Google Scholar
• Askanas V, Engel W K, Alvarez R B. Enhanced detection of congo‐red‐positive amyloid deposits in muscle fibers of inclusion body myositis and brain of Alzheimer's disease using fluorescence technique. Neurology 1993; 43: 1265–1267
   PubMedGoogle Scholar
• Linke R P. Highly sensitive diagnosis of amyloid and various amyloid syndromes using Congo red fluorescence. Virchows Arch 2000; 436: 439–448
   PubMed Web of Science ®Google Scholar
• Shively J E, Conrad H E. Formation of anhydrosugars in the chemical depolymerization of heparin. Biochemistty 1976; 15: 3932–3942
   PubMed Web of Science ®Google Scholar
• Snow A D, Kisilevsky R, Stephens C, Anastassiades T. Characterization of tissue and plasma glycosaminoglycans during experimental AA amyloidosis and acute inflammation. Qualitative and quantitative analysis. Lab Invest 1987; 56: 665–675
   PubMed Web of Science ®Google Scholar
• Saito H, Yamagata T, Suzuki S. Enzymatic methods for the determination of small quantities of isomeric chon‐droitin sulfates. J Biol Chem 1968; 243: 1536–1542
   PubMed Web of Science ®Google Scholar
• Scott J E, Dorling J. Differential staining of acid glycosaminoglycans (mucopolysaccharides) by alcian blue in salt solutions. Histochemie 1965; 5: 221–233
   PubMedGoogle Scholar
• Mowry R W, Scott J E. Observations on the basophilia of amyloids. Histochemie 1967; 10: 8–32
   PubMedGoogle Scholar
• Bruun C F, Rygg M, Nordstoga K, Sletten K, Marhaug G. Serum amyloid A protein in mink during endotoxin induced inflammation and amyloidogenesis. Scand J Immunol 1994; 40: 337–344
   PubMed Web of Science ®Google Scholar
• Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Nutl Acad Sci USA 1979; 76: 4350–4354
   PubMed Web of Science ®Google Scholar
• Laemmli U K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680–685
   PubMed Web of Science ®Google Scholar
• Zschiesche W, Jakob W. Pathology of animal amyloidoses. Pharmacol Ther 1989; 41: 49–83
   PubMed Web of Science ®Google Scholar
• Nordstoga K. The effect of long‐term challenge with endotoxin on infectious mink plasmacytosis. Acta Pathol Microbiol Scand [A] 1973; 81: 347–351
   PubMedGoogle Scholar
• Nordstoga K. Amyloidosis in mink induced by repeated injections of endotoxin. Acta Pathol Microbiol Scand [A] 1972; 80: 159–168
   PubMedGoogle Scholar
• Kisilevsky R. The relation of proteoglycans, serum amyloid P. and apo E to amyloidosis current status, 2000. Amyloid Int J Exp Clin Invest 2000; 7: 23–25
   PubMed Web of Science ®Google Scholar
• Pepys M B, Booth D R, Hutchinson W L, Gallimore J R, Collins P M, Hohenester E. Amyloid P Component. A critical review. Amyloid Int J Exp CIin Invest 1997; 4: 274–295
   Web of Science ®Google Scholar
• Gallo G, Wisniewski T, Choi‐Miura N H, Ghiso J, Frangione B. Potential role of apolipoprotein‐E in fibrillogenesis. Am J Pathol 1994; 145: 526–530
   PubMed Web of Science ®Google Scholar
• Wisniewski T, Frangione B. Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid. Neurosci Lett 1992; 135: 235–238
   PubMed Web of Science ®Google Scholar
• White R G, Henderson D C, Eslami M B, Neilsen K H. Localization of a protein antigen in the chicken spleen. Effect of various manipulative procedures on the morphogenesis of the germinal centre. Immunology 1975; 28: 1–21
   PubMed Web of Science ®Google Scholar
• Espenes A, Press C M, Dannevig B H, Landsverk T. Investigation of the structural and functional features of splenic ellipsoids in rainbow trout (Oncorhynchus mykiss). Cell Tissue Res 1995; 279: 469–474
   Web of Science ®Google Scholar
• Hardt F, Ranlov P. Transfer amyloidosis. Local and systemic amyloidosis in recipients of syngeneic spleen grafts from non‐amyloidotic, casein‐sensitized donor mice. Acta Pathol Microbiol Scand 1968; 73: 549–558
   PubMedGoogle Scholar
• Hardt F, Ranlov P. Transfer amyloidosis. Int Rev Exp Pathof 1976; 16: 273–334
   PubMedGoogle Scholar
• Axelrad M A, Kisilevsky R, Willmer J, Chen S J, Skinner M. Further characterization of amyloid‐enhancing factor. Lab Invest 1982; 47: 139–146
   PubMed Web of Science ®Google Scholar
• Cabana V G, Lukens J R, Rice K S, Hawkins T J, Getz G S. HDL content and composition in acute phase response in three species: triglyceride enrichment of HDL a factor in its decrease. J Lipid Res 1996; 37: 2662–2674
   PubMed Web of Science ®Google Scholar
• Marcovina S M, Gaur V P, Albers J J. Biological variability of cholesterol, triglyceride, low‐ and high‐ density lipoprotein cholesterol, lipoprotein(a), and apolipoproteins A‐I and B. Clin Chem 1994; 40: 574–578
   PubMedGoogle Scholar
• Husebekk A, Skogen B, Husby G. Characterization of amyloid proteins A. A. and SAA as apolipoproteins of high density lipoprotein (HDL). Displacement of SAA from the HDL‐SAA complex by apo A1 and apo AII. Scand J Immunol 1987; 25: 375–381
   PubMed Web of Science ®Google Scholar
• Glass C K, Pittman R C, Keller G A, Steinberg D. Tissue sites of degradation of apoprotein A‐I in the rat. J Biol Chem 1983; 258: 7161–7167
   PubMed Web of Science ®Google Scholar
• Husby G, Marhaug G, Dowton B, Sletten K, Sipe J D. Serum amyloid A (SAA): biochemistry, genetics and the pathogenesis of AA amyloidosis. Amyloid 1994; 1: 119–137
   Web of Science ®Google Scholar
• Yamada T, Wada A, Fukuda T, ltoh Y, Itoh K. Changes in plasma apolipoprotein A. I. and AII concentrations in murine reactive amyloidosis. Scand J Immunol 1999; 50: 475–478
   PubMedGoogle Scholar
• Wisniewski T, Golabek A A, Kida E, Wisniewski K E, Frangione B. Conformational mimicry in Alzheimer's disease. Role of apolipoproteins in amyloidogenesis. Am J Path01 1995; 147: 238–244
   PubMed Web of Science ®Google Scholar
• Harr S D, Uint L, Hollister R, Hyman B T, Mendez A J. Brain expression of apolipoproteins E, J, and A‐I in Alzheimer's disease. J Neurochem 1996; 66: 2429–2435
   PubMed Web of Science ®Google Scholar
• Bergstrlim J, Murphy C, Eulitz M, Weiss D T, Westermark G T, Solomon A, Westermark P. Codeposition of apolipoprotein A‐IV and transthyretin in senile systemic (ATTR) amyloidosis. Biochem Biophys Res Commun 2001; 285: 903–908
   PubMedGoogle Scholar
• Husby G, Natvig J B, Sletten K, Nordstoga K, Anders R F. An experimental model in mink for studying the relation between amyloid fibril protein A. A. and the related serum protein SAA. Scand J Immunol 1975; 4: 811–816
   PubMedGoogle Scholar
• Waalen K, Sletten K, Husby G, Nordstoga K. The primary structure of amyloid fibril protein AA in endotoxin‐induced amyloidosis of the mink. Eur J Biochem 1980; 104: 407–412
   PubMedGoogle Scholar
• Westermark P, Mucchiano G, Marthin T, Johnson K H, Sletten K. Apolipoprotein Al‐derived amyloid in human aortic atherosclerotic plaques. Am J Pathol 1995; 147: 1186–1192
   PubMed Web of Science ®Google Scholar
• Mucchiano G I, Haggqvist B, Sletten K, Westermark P. Apolipoprotein A‐I‐derived amyloid in atherosclerotic plaques of the human aorta. J Pathol 2001; 193: 270–275
   PubMed Web of Science ®Google Scholar
• Roertgen I C E, Lund E M, O'Brien T D, Westermark P, Hayden D W, Johnson K H. Apolipoprotein AI‐derived pulmonary vascular amyloid in aged dogs. Am J Pathol 1995; 147: 1311–1317
   PubMed Web of Science ®Google Scholar
• Sorci‐Thomas M G, Thomas M J. The effects of altered apolipoprotein A‐I structure on plasma HDL concentration. Trends Cardiovasc Med 2002; 12: 121–128
   PubMed Web of Science ®Google Scholar
• Baltz M L, Caspi D, Evans D J, Rowe I F, Hind C R, Pepys M B. Circulating serum amyloid P component is the precursor of amyloid P component in tissue amyloid deposits. Clin Exp Immunol 1986; 66: 691–700
   PubMedGoogle Scholar
• Dyck R F, Lockwood C M, Kershaw M, McHugh N, Duance V C, Baltz M L, Pepys M B. Amyloid P‐component is a constituent of normal human glomerular basement membrane. J Exp Med 1980; 152: 1162–1174
   PubMed Web of Science ®Google Scholar
• al‐Mutlaq H, Wheeler J, Robertson H, Watchorn C, Morley A R. Tissue distribution of amyloid P component as defined by a monoclonal antibody produced by immunization with human glomerular basement membranes. Histochem J 1993; 25: 219–227
   PubMedGoogle Scholar
• Inoue S, Kisilevsky R. A high resolution ultra‐structural study of experimental murine AA amyloid. Lab Invest 1996; 74: 670–683
   PubMed Web of Science ®Google Scholar
• Inoue S, Kuroiwa M, Kisilevsky R. AA protein in experimental murine AA amyloid fibrils: A high resolution ultrastructural and immunohistochemical study comparing aldehyde‐fixed and cryofixed tissues. Amyloid Int J Exp Clin Invest 2002; 9: 115–125
   PubMed Web of Science ®Google Scholar
• Magnus J H, Stenstad T. Proteoglycans and the extracellular matrix in amyloidosis. Amyloid J Protein Folding Dis 1997; 4: 121–134
   Web of Science ®Google Scholar